NIH-funded research R01 grant

Oxidative stress and tiny blood vessels after gestational diabetes

Official title: The role of oxidative stress in reduced microvascular function after gestational diabetes

Funded at University of Iowa · NIH-11377501 · Data updated 2026-11-12

This study looks at why women who had gestational diabetes may have higher risk of heart and diabetes problems, by checking how oxidative stress affects tiny blood vessels.

More Diabetes research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Iowa
NIH-funded
Lab location1 site (Iowa City, United States)
Project startJuly 1, 2023
Project endJune 30, 2028
Funding year2026
Award (this year)$604,097
NIH project number5R01HL169201-04
Project IDNIH-11377501 on NIH RePORTER

Who could benefit from this research

Could help

Women with a history of gestational diabetes who are otherwise healthy at study entry.

Less likely to help

Women without a history of gestational diabetes or those with significant comorbidities may not benefit from this specific research.

What this research studies

We will examine how oxidative stress affects the small blood vessels’ ability to respond to insulin and nitric oxide in women who previously had gestational diabetes, using noninvasive assessments and in vivo measurements. The team will test whether NADPH oxidase drives this problem and whether its inhibition can improve vascular function. The research will involve detailed vascular tests, possible biopsies or blood analyses, and careful monitoring over time to relate vascular changes to future risk. If successful, this work could point toward strategies to prevent cardiovascular disease and diabetes in women after GDM.

Why it matters

Potential benefit: If effective, findings could lead to preventative approaches to protect heart and metabolic health in women after gestational diabetes.

How similar studies have gone: Prior studies show endothelial and NO-dependent dilation is reduced after GDM and may improve with NADPH oxidase inhibition in early phases; further validation is needed.

Where this research is happening

  • University of Iowa
    Iowa City, United States
    Active

Researchers

  • Principal investigator: Stanhewicz, Anna — University of Iowa
  • Study coordinator: Stanhewicz, Anna

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.